Astrazeneca Pharma India falls; Sebi says exchanges to monitor delisting

Tags: Companies
Shares in Astrazeneca Pharma India Ltd fell 3 percent after the SEBI on Tuesday said stock exchanges will closely monitor the company's delisting process and promptly report any aberrations.

"The promoters of M/s Astrazeneca Pharma India Ltd. shall finally purchase shares from public shareholders in the delisting offer only after seeking approval of the Bombay Stock Exchange Limited and National Stock Exchange Limited," added the Securities and Exchange Board of India in an order.

The regulator also said it came across certain reports that the offer for sale (OFS) of the shares of Astrazeneca Pharma India Ltd carried out by its promoter AstraZeneca Pharmaceuticals AB Sweden on May 26, 2013 was a deliberate attempt to subsequently get the shares of the Indian unit delisted at ease.

It was also reported that more than 94 percent of total shares offered through OFS had been subscribed by six foreign institutional investors including DB International Asia Ltd, Suffolk (Mauritius), Morgan Stanley Asia (Singapore) PTE, BNP Paribas Arbitrage, Manfield (Mauritius) Ltd and Merrill Lynch Capital Markets Espana S.A. SVB.

EDITORIAL OF THE DAY

  • The govt must get more citizens into the tax net to curb black money

    Prime minister Narendra Modi’s mild warning to black money hoarders to come clean by September is timely, but not enough.

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Tushar Gandhi

The shame of rejecting our women

Recently, three young women broke into the elite male basti­on ...

Rajgopal Nidamboor

The rainbow fusion of our being

Our mind isn’t a metaph­or. It is part of a ...

Dharmendra Khandal

The unfortunate death of a tigress & its repercussions

In nature it is not easy to gather investigative evidences, ...